Suppr超能文献

关于内镜鼻内手术后应用羟基磷灰石颅骨成形术和鼻中隔瓣治疗鞍结节脑膜瘤或颅咽管瘤的2年疗效的多中心研究。

Multicenter study on 2-year outcomes of dual application of hydroxyapatite cranioplasty and a nasoseptal flap following endoscopic endonasal surgery for tuberculum sellae meningiomas or craniopharyngiomas.

作者信息

Kong Doo-Sik, Kim Yong Hwy, Hong Sang Duk, Ryu Gwanghui, Kim Ji Heui, Hong Chang-Ki, Kim Young-Hoon

机构信息

1Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul.

2Department of Neurosurgery, Seoul National University Hospital, Seoul National University School of Medicine, Seoul.

出版信息

Neurosurg Focus. 2025 Feb 1;58(2):E2. doi: 10.3171/2024.11.FOCUS24624.

Abstract

OBJECTIVE

The authors evaluated the intermediate-term outcomes of a skull base reconstruction technique using hydroxyapatite cranioplasty combined with a nasoseptal flap following endoscopic endonasal surgery (EES) for suprasellar tumors. Specifically, the evaluation focused on the avoidance of lumbar CSF drainage, prevention of CSF leakage, and incidence of postoperative complications, including meningitis and nasoseptal flap necrosis, during a minimum follow-up of 2 years.

METHODS

This multicenter study included patients who met the following criteria: 1) underwent EES for tuberculum sellae meningiomas or craniopharyngiomas, 2) received dual application of hydroxyapatite cranioplasty and reconstruction using a nasoseptal flap, 3) had a follow-up duration of at least 2 years, and 4) did not undergo lumbar drainage of CSF postoperatively. The success rate of reconstruction was determined based on postoperative CSF leakage, associated complications, meningitis, postoperative hospital length of stay (LOS), and would dehiscence.

RESULTS

A total of 198 patients from three institutions diagnosed with tuberculum sellae meningioma (86 patients) or craniopharyngioma (112 patients) were included in this study. The median follow-up duration was 39 months. No patient underwent postoperative lumbar drainage of CSF. Postoperatively, only 3 patients (1.5%) experienced CSF leaks requiring reoperation. The median hospital LOS after surgery was 5 days. Other postoperative complications included atypical meningitis in 5 patients and wound dehiscence in 3 patients during the follow-up period. All patients with nonbacterial meningitis were treated with intravenous antibiotics and dexamethasone medication for 2 weeks.

CONCLUSIONS

The combination of hydroxyapatite cranioplasty and a nasoseptal flap in reconstruction following EES decreased the requirement for postoperative lumbar CSF drainage and shortened hospital LOSs with minimal morbidities. Nevertheless, careful attention to the risks of meningitis and central necrosis of a nasoseptal flap is crucial for optimizing patient outcomes.

摘要

目的

作者评估了在经鼻内镜手术(EES)治疗鞍上肿瘤后,使用羟基磷灰石颅骨成形术联合鼻中隔瓣进行颅底重建技术的中期疗效。具体而言,评估重点在于避免腰椎脑脊液引流、预防脑脊液漏以及术后并发症的发生率,包括脑膜炎和鼻中隔瓣坏死,随访时间至少为2年。

方法

这项多中心研究纳入了符合以下标准的患者:1)因鞍结节脑膜瘤或颅咽管瘤接受EES;2)接受羟基磷灰石颅骨成形术和鼻中隔瓣重建双重治疗;3)随访时间至少为2年;4)术后未进行腰椎脑脊液引流。根据术后脑脊液漏、相关并发症、脑膜炎、术后住院时间(LOS)和伤口裂开情况确定重建成功率。

结果

本研究共纳入来自三个机构的198例诊断为鞍结节脑膜瘤(86例)或颅咽管瘤(112例)的患者。中位随访时间为39个月。没有患者术后进行腰椎脑脊液引流。术后,只有3例患者(1.5%)出现脑脊液漏需要再次手术。术后中位住院时间为5天。随访期间其他术后并发症包括5例非典型脑膜炎和3例伤口裂开。所有非细菌性脑膜炎患者均接受静脉抗生素和地塞米松治疗2周。

结论

EES术后重建中使用羟基磷灰石颅骨成形术和鼻中隔瓣可减少术后腰椎脑脊液引流的需求,缩短住院时间,且发病率最低。然而,密切关注脑膜炎和鼻中隔瓣中央坏死的风险对于优化患者预后至关重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验